Viewing Study NCT03362502


Ignite Creation Date: 2025-12-25 @ 3:43 AM
Ignite Modification Date: 2026-06-26 @ 5:09 AM
Study NCT ID: NCT03362502
Status: TERMINATED
Last Update Posted: 2025-09-15
First Post: 2017-11-29
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-01-23
Start Date Type: ACTUAL
Primary Completion Date: 2022-03-28
Primary Completion Date Type: ACTUAL
Completion Date: 2025-07-28
Completion Date Type: ACTUAL
First Submit Date: 2017-11-29
First Submit QC Date: None
Study First Post Date: 2017-12-05
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-03-27
Results First Submit QC Date: None
Results First Post Date: 2024-09-20
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-08-25
Last Update Post Date: 2025-09-15
Last Update Post Date Type: ESTIMATED